SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gulhan Kanat Unler, Gulsum Teke Ozgur, Huseyin Savas Gokturk, Aydın Karakoca, Ozgur Hilal Erinanc, A Comparison of Five Different Treatment Regimens as the First-Line Treatment of Helicobacter pylori in Turkey, Helicobacter, 2016, 21, 1
  2. 2
    Elizabeth A. Marcus, George Sachs, Yi Wen, David R. Scott, Phosphorylation-dependent and Phosphorylation-independent Regulation of Helicobacter pylori Acid Acclimation by the ArsRS Two-component System, Helicobacter, 2016, 21, 1
  3. 3
    E. A. Marcus, G. Sachs, D. R. Scott, Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics, Alimentary Pharmacology & Therapeutics, 2015, 42, 7
  4. 4
    Takuma Kagami, Mitsushige Sugimoto, Hitomi Ichikawa, Shu Sahara, Takahiro Uotani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima, Takahisa Furuta, One-day front-loading with four doses of rabeprazole followed by a standard twice-daily regimen provides sufficient acid inhibition in extensive metabolizers of CYP2C19, European Journal of Clinical Pharmacology, 2015, 71, 12, 1467

    CrossRef

  5. 5
    Yuuichi Sakurai, Akira Nishimura, Gale Kennedy, Mark Hibberd, Richard Jenkins, Hiroyuki Okamoto, Tomoki Yoneyama, Helen Jenkins, Kiyoshi Ashida, Shin Irie, Jörg Täubel, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects, Clinical and Translational Gastroenterology, 2015, 6, 6, e94

    CrossRef

  6. 6
    Mitsushige Sugimoto, Takahiro Uotani, Shu Sahara, Hitomi Ichikawa, Mihoko Yamade, Ken Sugimoto, Takahisa Furuta, Efficacy of Tailored Helicobacter pylori Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion, Helicobacter, 2014, 19, 4
  7. 7
    George Sachs, Jai Moo Shin, Keith Munson, David R. Scott, Gastric Acid-Dependent Diseases: A Twentieth-Century Revolution, Digestive Diseases and Sciences, 2014, 59, 7, 1358

    CrossRef

  8. 8
    Ling Ren, Hong Lu, Hai Yan Li, Ling Yin Zhu, Xiao Qing Xu, Li Yang Gu, Zhi Zheng Ge, Xiao Bo Li, New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China, Journal of Digestive Diseases, 2014, 15, 11
  9. 9
    G. Sachs, E.A. Marcus, Y. Wen, D.R. Scott, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  10. 10
    Sotirios D. Georgopoulos, Elias Xirouchakis, Beatriz Martinez-Gonzalez, Dionyssios N. Sgouras, Charikleia Spiliadi, Andreas F. Mentis, Fotini Laoudi, Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area, Helicobacter, 2013, 18, 6
  11. 11
    Shijian Chu, Mitchell L. Schubert, Gastric secretion, Current Opinion in Gastroenterology, 2013, 29, 6, 636

    CrossRef